Mark Marzinke
Johns Hopkins University
H-index: 47
North America-United States
Top articles of Mark Marzinke
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017 … | The Lancet HIV | Aditya H Gaur Edmund V Capparelli Katherine Calabrese Kristin Baltrusaitis Mark A Marzinke | 2024/4/1 |
Reply to Niu and Drain | Clinical Infectious Diseases | Peter L Anderson Mark A Marzinke David V Glidden | 2024/3/15 |
Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry | Journal of Pharmaceutical and Biomedical Analysis | Aashish Pandey Amelia Price Nadia Ayala-Lopez Kyana Y Garza Mark A Marzinke | 2024/6/15 |
Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States | Journal of the International AIDS Society | Albert Y Liu Holly Gundacker Barbra Richardson Beatrice A Chen Craig Hoesley | 2024/3 |
Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study | AIDS and Behavior | KR Amico KH Mayer RJ Landovitz M Marzinke C Hendrix | 2024/3 |
Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring | The Journal of Infectious Diseases | Randy M Stalter Tracy Q Dong Craig W Hendrix Thesla Palanee-Phillips Ariane van der Straten | 2024/4/15 |
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021 | Emerging Infectious Diseases | Jessica Justman Timothy Skalland Ayana Moore Christopher I Amos Mark A Marzinke | 2024/2 |
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01) | The Journal of Infectious Diseases | Ethel D Weld Ian McGowan Peter Anton Edward J Fuchs Ken Ho | 2023/11/29 |
The VALIDity of Laboratory Developed Tests: Leave it to the experts? | Journal of Mass Spectrometry and Advances in the Clinical Lab | Mark A Marzinke William Clarke Dennis J Dietzen Andrew N Hoofnagle Gwendolyn A McMillin | 2023 |
Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria | PloS one | Olusegun A Adeyemi Rebecca G Nowak Mark Marzinke Daniel Morgan Nadia Sam-Agudu | 2023/3/16 |
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and … | The Lancet HIV | Raphael J Landovitz Brett S Hanscom Meredith E Clement Ha V Tran Esper G Kallas | 2023/12/1 |
An introduction from the Laboratory Developed Tests special issue guest editors | Journal of Mass Spectrometry and Advances in the Clinical lab | Melissa M Budelier Mark A Marzinke Jacqueline A Hubbard | 2023/8 |
EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water | AIDS research and human retroviruses | Adriana Andrade Edward J Fuchs Mark A Marzinke Sandra Abdul Massih Jennifer Breakey | 2023/1/1 |
Inclusion of transgender and gender diverse people in phase III trials: examples from HIV pharmacologic prevention studies | Lauren R Cirrincione Victoria Luna Brennan Grieve Jay Holloway Mark A Marzinke | 2023/3 | |
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the … | The Lancet HIV | Mark A Marzinke Brett Hanscom Zhe Wang Steven A Safren Christina Psaros | 2023/11/1 |
AACC/NKF guidance document on improving equity in chronic kidney disease care | The Journal of Applied Laboratory Medicine | Christina C Pierre Mark A Marzinke Sofia B Ahmed David Collister Jessica M Colón-Franco | 2023/7 |
Interaction of depot medroxyprogesterone acetate and tenofovir disoproxil fumarate/emtricitabine on peripheral blood mononuclear cells and cervical tissue susceptibility to HIV … | JAIDS Journal of Acquired Immune Deficiency Syndromes | Jenell S Coleman Clarissa P Diniz Edward J Fuchs Mark A Marzinke Wutyi Aung | 2023/1/1 |
High isoniazid exposures when administered with rifapentine once weekly for latent tuberculosis in individuals with human immunodeficiency virus | Antimicrobial agents and chemotherapy | Ryan T Jarrett Yuri van der Heijden Matthew S Shotwell Violet Chihota Mark A Marzinke | 2023/2/16 |
Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma | Journal of Chromatography A | Neus Fabregat-Cabello Juan V Sancho Andreu Vidal Florenci V González Antoni Francesc Roig-Navarro | 2014/2/7 |
Preclinical considerations for long-acting delivery of tenofovir alafenamide from subdermal implants for HIV pre-exposure prophylaxis | Pharmaceutical Research | Manjula Gunawardana Mariana Remedios-Chan Debbie Sanchez Rob Fanter Simon Webster | 2023/7 |
